The Innovative Medicines Initiative: an engine for regulatory science

被引：31

作者：

Goldman, Michel ^{[1
]}

Seigneuret, Nathalie ^{[1
]}

Eichler, Hans-Georg ^{[2
]}

机构：

[1] Innovat Med Initiat, B-1060 Brussels, Belgium

[2] European Med Agcy, London E14 5EU, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2015年 / 14卷 / 01期

关键词：

D O I：

10.1038/nrd4520

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Since its launch in 2008, the Innovative Medicines Initiative has catalysed the formation of many consortia to address challenges in drug development and regulation. As it moves into its second phase, we highlight key outcomes so far and lessons learned.

引用

页码：1 / 2

页数：2